Stockhead on MSN
Health check: Actinogen awaits crucial 'futility' ruling on Alzheimer's disease trial
Actinogen Medical soon should find out whether its pivotal Xanamia Alzheimer's trial is futile, or hitting the right notes. .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results